[1] 江载芳,申昆玲,沈颖.褚福棠实用儿科学[M].8版.北京:人民卫生出版社,2015:491-495. [2] Shane AL, Sánchez PJ, Stoll BJ.Neonatal sepsis[J]. Lancet, 2017, 390(10104):1770-1780. DOI: 10.1016/S0140-6736(17)31002-4. [3] Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, et al.The global burden of paediatric and neonatal sepsis: a systematic review[J]. Lancet Respir Med, 2018, 6(3):223-230. DOI: 10.1016/S2213-2600(18)30063-8. [4] 邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].4版.北京:人民卫生出版社,2011:340-347. [5] 中华医学会儿科学分会新生儿学组,中国医师协会新生儿科医师分会感染专业委员会.新生儿败血症诊断及治疗专家共识(2019年版)[J].中华儿科杂志,2019,57(4):252-257. DOI:10.3760/cma.j.issn.0578?1310.2019.04.005. [6] 陆文峰,张洁,方成志.新生儿败血症发病情况及早期诊断指标分析[J].中国妇幼健康研究,2017,28(8):908-910. DOI:10.3969/j.issn.1673-5293.2017.08.005. [7] Sharma D, Farahbakhsh N, Shastri S, et al.Biomarkers for diagnosis of neonatal sepsis: a literature review[J]. J Matern Fetal Neonatal Med, 2018, 31(12):1646-1659. DOI: 10.1080/14767058.2017.1322060. [8] 彭蕾,朱艳萍.血清降钙素原和白细胞介素-6及高敏C反应蛋白对新生儿感染性疾病早期诊断价值的研究进展[J].中华实用诊断与治疗杂志,2018,32(4):408-410. DOI:10.13507/j.issn.1674-3474.2018.04.030. [9] 徐美莲,杨长仪,陈涵强.白细胞介素-6在新生儿感染性疾病早期诊断中的研究进展[J].中国新生儿科杂志,2012,27(2):131-134. DOI:10.3969/j.issn.1673-6710. 2012. 02.020. [10] 韦叶生,刘运广.白细胞介素-6基因多态性与疾病的易感性[J].国外医学(遗传学分册),2005,28(5):302-305. DOI:10.3760/cma.j.issn.1673-4386.2005.05.013. [11] 盛红玲,姜元培,马燕,等.血清降钙素原、超敏C反应蛋白及白细胞介素-6在小儿急性上呼吸道感染中的诊断价值[J].国际检验医学杂志,2016,37(9):1207-1209. DOI:10.3969/j.issn.1673-4130.2016.09.021. [12] Narazaki M, Kishimoto T.The Two-Faced Cytokine IL-6 in Host Defense and Diseases[J]. Int J Mol Sci, 2018, 19(11):3528. DOI: 10.3390/ijms19113528. [13] Tanaka T, Narazaki M, Kishimoto T.IL-6 in inflammation, immunity, and disease[J]. Cold Spring Harb Perspect Biol, 2014, 6(10):a016295. DOI: 10.1101/cshperspect.a016295. [14] Jones SA, Scheller J, Rose-John S.Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling[J]. J Clin Invest, 2011, 121(9):3375-3383. DOI: 10.1172/JCI57158. [15] 周启立,刘利蕊,郭健,等.白细胞介素-6、降钙素原、C-反应蛋白对足月新生儿社区获得性败血症晚发型的早期诊断价值[J].中国妇幼保健,2019,34(8):1770-1773. DOI:10.7620/zgfybj.j.issn.1001-4411.2019.08.26. [16] Sun B, Liang LF, Li J, et al.A meta-analysis of interleukin-6 as a valid and accurate index in diagnosing early neonatal sepsis[J]. Int Wound J, 2019, 16(2):527-533. DOI: 10.1111/iwj.13079. [17] Mirzarahimi M, Barak M, Eslami A, et al.The role of interleukin-6 in the early diagnosis of sepsis in premature infants[J]. Pediatr Rep, 2017, 9(3):7305. DOI: 10.4081/pr.2017.7305. [18] Wu Y, Wang M, Zhu Y, et al.Serum interleukin-6 in the diagnosis of bacterial infection in cirrhotic patients: A meta-analysis[J]. Medicine (Baltimore), 2016, 95(41):e5127. DOI: 10.1097/MD.0000000000005127. [19] Boskabadi H, Zakerihamidi M.Evaluate the diagnosis of neonatal sepsis by measuring interleukins: A systematic review[J]. Pediatr Neonatol, 2018, 59(4):329-338. DOI: 10.1016/j.pedneo.2017.10.004. [20] Celik IH, Demirel G, Uras N, et al.The role of serum interleukin-6 and C-reactive protein levels for differentiating aetiology of neonatal sepsis[J]. Arch Argent Pediatr, 2015, 113(6):534-537. DOI: 10.5546/aap.2015.534. [21] Prashant A, Vishwanath P, Kulkarni P, et al.Comparative assessment of cytokines and other inflammatory markers for the early diagnosis of neonatal sepsis-a case control study[J]. PLoS One, 2013, 8(7):e68426. DOI: 10.1371/journal.pone.0068426. [22] De Buck M, Gouwy M, Wang JM, et al.The cytokine-serum amyloid A-chemokine network[J]. Cytokine Growth Factor Rev, 2016, 30:55-69. DOI: 10.1016/j.cytogfr.2015.12.010. [23] Ye RD, Sun L.Emerging functions of serum amyloid A in inflammation[J]. J Leukoc Biol, 2015, 98(6):923-929. DOI: 10.1189/jlb.3VMR0315-080R. [24] 万颖蕾,李文静,项明洁.血清淀粉样蛋白A在感染性疾病中的诊断价值[J].诊断学理论与实践,2015,14(2):190-192. DOI:10.16150/j.1671-2870.2015.02.022. [25] De Buck M, Gouwy M, Wang JM, et al.Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults[J]. Curr Med Chem, 2016, 23(17):1725-1755. DOI: 10.2174/0929867323666160418114600. [26] Ko YL, Hsu LA, Wu S, et al.CRP and SAA1 Haplotypes Are Associated with Both C-Reactive Protein and Serum Amyloid A Levels: Role of Suppression Effects[J]. Mediators Inflamm, 2016, 2016:5830361. DOI: 10.1155/2016/5830361. [27] Tannock LR, De Beer MC, Ji A, et al.Serum amyloid A3 is a high density lipoprotein-associated acute-phase protein[J]. J Lipid Res, 2018, 59(2):339-347. DOI: 10.1194/jlr.M080887. [28] 吴跃平,王丹,黄娟,等.超敏C-反应蛋白及血清淀粉样蛋白A在儿科感染性疾病中的研究[J].检验医学与临床,2015,12(11):1535-1537. DOI:10.3969/j.issn.1672-9455. 2015. 11.016. [29] 李福刚,雷蕾,石晓强,等.血清淀粉样蛋白A(SAA)水平检测在临床实验诊断及健康监测中的应用[J].现代检验医学杂志,2019,34(3):1-5. DOI:10.3969/j.issn.1671-7414. 2019. 03.001. [30] 中国中西医结合学会检验医学专业委员会.血清淀粉样蛋白A在感染性疾病中临床应用的专家共识[J].中华检验医学杂志,2019,42(3):186-192. DOI:10.3760/cma.j.issn.1009-9158.2019.03.008. [31] Hedegaard SS, Wisborg K, Hvas AM.Diagnostic utility of biomarkers for neonatal sepsis--a systematic review[J]. Infect Dis (Lond), 2015, 47(3):117-124. DOI: 10.3109/00365548.2014.971053. [32] Arnon S, Litmanovitz I, Regev R, et al.Serum amyloid A protein is a useful inflammatory marker during late-onset sepsis in preterm infants[J]. Biol Neonate, 2005, 87(2):105-110. DOI: 10.1159/000081979. [33] Arnon S, Litmanovitz I, Regev RH, et al.Serum amyloid A: an early and accurate marker of neonatal early-onset sepsis[J]. J Perinatol, 2007, 27(5):297-302. DOI: 10.1038/sj.jp.7211682. [34] 岑臻,张丙宏.新生儿脐动脉血血清淀粉样蛋白A、C一反应蛋白水平变化及临床意义[J].中国妇幼保健,2019,34(7):1582-1585. DOI:10.7620/zgfybj.j.issn.1001-4411. 2019. 07.40. [35] Arnon S, Litmanovitz I, Regev R, et al.The prognostic virtue of inflammatory markers during late-onset sepsis in preterm infants[J]. J Perinat Med, 2004, 32(2):176-180. DOI: 10.1515/JPM.2004.032. [36] 户梅芳. 血清C反应蛋白、降钙素原及淀粉样蛋白A动态监测在细菌性新生儿败血症诊断及疗效评估中的应用[J].临床医药实践,2019,28(3):214-217. DOI:10.16047/j.cnki.cn14-1300/r.2019.03.021. |